We are delighted to announce that QUAMED has signed a contract with Relief International to run an exciting 4-year project: “Improving Access to Quality Medicines and Medical Supplies in Fragile and Conflict-Affected Countries”. The project will focus on building the capacity of 20 local medical product suppliers across Afghanistan, Yemen, Myanmar, and Syria. Following market ...
We would like to congratulate the MCAZ on becoming the 6th country in Africa to achieve WHO maturity level 3. We are indirectly profiting from their expertise as our colleague Linda Mudyiwenyama was part of the MCAZ team up to two years ago. Linda is currently collaborating with the Rwanda FDA in their quest to ...
Excited to share a new analytical framework for evaluating access to medicines from a health systems perspective! Developed from a study on childhood oncology medicines in South Africa, this framework focuses on eight key pharmaceutical processes to identify barriers and facilitators to access. Targeting national processes guides effective policy development to improve healthcare outcomes. #HealthSystems ...
A recent study assessed access to mifepristone, misoprostol, and contraceptive medicines in eight Eastern Mediterranean countries, highlighting significant gaps. Despite their critical role in reducing maternal mortality, most countries did not include all WHO essential contraceptives in national guidelines. Only Lebanon and Pakistan had comprehensive family planning guidelines, and only Afghanistan and Lebanon included mifepristone ...
QUAMED (www.quamed.org) is a not-for-profit organisation specialising in various aspects of pharmaceutical quality assurance. We conduct pharmaceutical assessments and audits, develop and facilitate training courses around pharmaceutical quality, auditing and inspection and organise and provide technical assistance in the field of pharmaceutical quality assurance. We are starting a new project in Senegal with as objective ...
Excited to announce a new Wellcome Trust contract opportunity focused on ‘Regulatory Pathways and Systems for Snakebite Treatments’. They are seeking an external expert in regulatory affairs for a project commitment of up to 2 days per week, over 12 months, with a fee of £700/day. Proposals are due by 21 June 2024. More details ...
On Monday 20th of May 2024, the WHO approved 33 national and regional regulatory authorities, including the U.S. FDA and the European Medicines Regulatory Network (EMRN), as WHO Listed Authorities (WLAs), bringing the total to 36 WLAs from 34 Member States since March 2022. This milestone enhances global cooperation and regulatory standards for medicine and vaccine ...
This study examined 260 samples of 13 essential medicines in Enugu and Anambra, Nigeria, revealing that 25.4% did not meet USP 42 standards. Dexamethasone tablets had a 95% failure rate, and noncommunicable disease drugs showed higher non-compliance (21.2%) than anti-infectives (17.6%). OOS rates were similar between licensed vendors (25.2%) and market vendors (25.5%), with only ...
Sustainable access to affordable medicines is a global health issue, even for high-income countries. The fifth PPRI Conference, held in Vienna on 25-26 April 2024, will discuss innovative pharmaceutical policies to tackle current and future challenges. The event invites researchers, policymakers, payers, patients, industry representatives, and health professionals. Key topics include best practices and lessons ...
Join on May 21st from 12:45 PM to 2:00 PM GMT+2 for a discussion with Sadiq Samater, a Quality Control Consultant at the Somaliland Quality Control Commission. Sadiq, a UK pharmacist, will address the challenges of substandard and falsified medicines in Somaliland and the actions taken by SQCC. Don’t miss this opportunity to learn and ...
Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.
En poursuivant votre visite sur ce site, vous acceptez l'utilisation de cookies En savoir plus
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.